Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of PCSK9 inhibitors on remnant cholesterol and lipid residual risk: The LIPID-REAL registry.
Cordero A, Fernández Olmo MR, Cortez Quiroga GA, Romero-Menor C, Fácila L, Seijas-Amigo J, Rondán Murillo J, Sandin M, Rodríguez-Mañero M, Bello Mora MC, Valle A, Fornovi A, Freixa Pamias R, Bañeras J, Blanch García P, Clemente Lorenzo MM, Sánchez-Álvarez S, López-Rodríguez L, González-Juanatey JR. Cordero A, et al. Among authors: freixa pamias r. Eur J Clin Invest. 2022 Dec;52(12):e13863. doi: 10.1111/eci.13863. Epub 2022 Sep 5. Eur J Clin Invest. 2022. PMID: 36039486
Should atrial fibrillation be considered a vascular disease? The need for a comprehensive vascular approach.
Escobar-Cervantes C, Reino AP, Díez-Villanueva P, Facila L, Freixa-Pamias R, Valle A, Almendro-Delia M, Bonanad C, Vivas D, Suarez C. Escobar-Cervantes C, et al. Among authors: freixa pamias r. Expert Rev Cardiovasc Ther. 2023 Jul-Dec;21(11):779-790. doi: 10.1080/14779072.2023.2272652. Epub 2023 Dec 10. Expert Rev Cardiovasc Ther. 2023. PMID: 37874226
Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study.
López-Gálvez R, Rivera-Caravaca JM, Anguita Sánchez M, Sanmartín Fernández M, Rafols C, Pérez-Cabeza AI, Barón Esquivias G, Lekuona Goya I, Vázquez Rodríguez JM, Cosín Sales J, Arribas Ynsaurriaga F, Barrios V, Freixa-Pamias R, Marín F. López-Gálvez R, et al. Among authors: freixa pamias r. Eur J Clin Invest. 2022 Sep;52(9):e13788. doi: 10.1111/eci.13788. Epub 2022 Apr 14. Eur J Clin Invest. 2022. PMID: 35395094
Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry.
Esteve-Pastor MA, Rivera-Caravaca JM, Roldán V, Sanmartin Fernández M, Arribas F, Masjuan J, Barrios V, Cosin-Sales J, Freixa-Pamias R, Recalde E, Pérez-Cabeza AI, Manuel Vázquez Rodríguez J, Ràfols Priu C, Anguita Sánchez M, Lip GYH, Marin F. Esteve-Pastor MA, et al. Among authors: freixa pamias r. Eur Heart J Cardiovasc Pharmacother. 2022 Dec 15;9(1):38-46. doi: 10.1093/ehjcvp/pvac060. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 36318457
Prognosis and management of acute coronary syndrome in Spain in 2012: the DIOCLES study.
Barrabés JA, Bardají A, Jiménez-Candil J, del Nogal Sáez F, Bodí V, Basterra N, Marco E, Melgares R, Cuñat de la Hoz J, Fernández-Ortiz A; investigators of DIOCLES study. Barrabés JA, et al. Rev Esp Cardiol (Engl Ed). 2015 Feb;68(2):98-106. doi: 10.1016/j.rec.2014.03.010. Epub 2014 Jun 11. Rev Esp Cardiol (Engl Ed). 2015. PMID: 25623429
[Cancer and cardiovascular risk].
Blanch Gracia P, Mena Sebastià E, Villanueva Vázquez R, Tirapu Sola L, Losa Gaspà F, Freixa-Pamias R, Armario P. Blanch Gracia P, et al. Among authors: freixa pamias r. Hipertens Riesgo Vasc. 2021 Jul-Sep;38(3):e1-e9. doi: 10.1016/j.hipert.2021.02.006. Epub 2021 Mar 8. Hipertens Riesgo Vasc. 2021. PMID: 33706995 Spanish.
Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries.
Marin F, Fernández MS, Lekuona I, Arribas F, Barón-Esquivias G, Barrios V, Cosin-Sales J, Freixa-Pamias R, Masjuan J, Pérez-Cabeza AI, Schilling VR, Vázquez Rodríguez JM, Priu CR, Sánchez MA. Marin F, et al. Among authors: freixa pamias r. J Comp Eff Res. 2022 Nov;11(16):1173-1184. doi: 10.2217/cer-2022-0111. Epub 2022 Sep 23. J Comp Eff Res. 2022. PMID: 36148923 Free article.
30 results